Clinical review: Type 1 diabetes and latent autoimmune diabetes in adults: One end of the rainbow

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 5, 2006, Pages 1654-1659

  Leslie, R David G ^a,d   Williams, Rhys ^b   Pozzilli, Paolo ^a,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; DATA ANALYSIS; HUMAN; IMMUNE RESPONSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; HUMANS;

EID: 33646393245     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-1623     Document Type: Review

References (67)

1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 1998 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 21:S3-S519
2. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR 1993 Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:359-362
3. Zimmet PZ, Elliot RB, Mackay IR, Rowley MJ, Pilcher CC, Knowles WJ 1994 Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus: frequency and segregation by age and gender. Diabet Med 11:866-871
4. Kobayashi T, Tamemoto K, Nakanishi K, Kato N, Okubo M, Kajio H, Sugimoto T, Murase T, Kosaka K 1993 Immunogenetic and clinical characterization of slowly progressive IDDM. Diabetes Care 16:780-788
5. Naik RG, Palmer JP 2003 Latent autoimmune diabetes in adults (LADA). Rev Endocr Metab Disord 4:233-241
6. Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC 2005 Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48:2206-2212
7. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R 1997 UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. U.K. Prospective Diabetes Study Group. Lancet 350:1288-1293
8. Hosszufalusi N, Vatay A, Rajczy K, Prohaszka Z, Pozsonyi E, Horvath L, Grosz A, Gero L, Madacsy L, Romics L, Karadi I, Fust G, Panczel P 2003 Similar genetic features and different islet cell autoantibody pattern of latent autoimmune diabetes in adults (LADA) compared with adult-onset type 1 diabetes with rapid progression. Diabetes Care 26:452-457
9. Zinman B, Kahn SE, Haffner SM, O'Neill MC, Heise MA, Freed MI; ADOPT Study Group 2004 Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe. Diabetes 53:3193-3200
10. Leslie RD, Delli Castelli M 2004 Age-dependent influences on the origins of autoimmune diabetes: evidence and implications. Diabetes 53:3033-3040
11. Redondo MJ, Yu L, Hawa M, Mackenzie T, Pyke DA, Eisenbarth GS, Leslie RDG 2001 Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia 44:354-362
12. Kumar D, Gemayel NS, Deapen D, Kapadia D, Yamashita PH, Lee M, Dwyer JH, Roy-Burman P, Bray GA, Mach TM 1993 North-American twins with IDDM: genetic, etiological, and clinical significance of disease concordance according to age, zygosity, and the interval after diagnosis in first twin. Diabetes 42:1351-1363
13. Hyttinen V, Kaprio J, Kinnunen L, Koskenvuo M, Tuomilehto J 2003 Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52:1052-1055
14. Field LL 2002 Genetic linkage and association studies of type 1 diabetes: challenges and rewards. Diabetologia 45:21-35
15. Salvetti M, Ristori G, Bomprezzi R, Pozzilli P, Leslie RDG 2000 Twins: mirrors of the immune system. Immunology Today 21:342-347
16. Lambert AP, Gillespie KM, Thomson G, Cordell HJ, Todd JA, Gale EA, Bingley PJ 2004 Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 89:4037-4043
17. Greenbaum CJ, Schatz DA, Cuthbertson D, Zeidler A, Eisenbarth GS, Krischer JP 2000 Islet cell antibody-positive relatives with human leukocyte antigen DQA1* 0102, DQB1*0602: identification by the Diabetes Prevention Trial-type 1. J Clin Endocrinol Metab 85:1255-1260
18. Sabbah E, Savola K, Ebeling T, Kulmala P, Vahasalo P, Ilonen J, Salmela PI, Knip M 2000 Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 23:1326-1332
19. Vanderwalle CL, Cecraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK, the Belgian Diabetes Register 1993 Insulin antibodies and high titre islet cell antibodies are preferentially associated with the HLA DQA1*03100- DQB1*0302 haplotype at clinical onset of type 1 (insulin-dependent) diabetes mellitus before age 10 years but not at onset between age 10 and 40 years. Diabetologia 36:1155-1162
20. Petrone A, Bugawan TL, Mesturino CA, Nisticò L, Galgani A, Giorgi G, Cascino I, Erlich HA, Di Mario U, Buzzetti R 2001 The distribution of HLA class II susceptible/protective haplotypes could partially explain the low incidence of type 1 diabetes in continental Italy (Lazio region). Tissue Antigens 58:385-394
21. Vatay A, Rajczy K, Pozsonyi E, Hosszufalusi N, Prohaszka Z, Fust G, Karadi I, Szalai C, Grosz A, Bartfai Z, Panczel P 2002 Differences in the genetic background of latent autoimmune diabetes in adults (LADA) and type 1 diabetes mellitus. Immunol Lett 84:109-115
22. Cerna M, Novota P, Kolostova K, Cejkova P, Zdarsky E, Novakova D, Kucera P, Novak J, Andel M 2003 HLA in Czech adult patients with autoimmune diabetes mellitus: comparison with Czech children with type 1 diabetes and patients with type 2 diabetes. Eur J Immunogenet 30:401-407
23. Horton V, Stratton I, Bottazzo GF, Shattock M, Mackay I, Zimmet P, Manley S, Holman R, Turner R, for the U.K. Prospective Diabetes Study (UKPDS) Group 1999 Genetic heterogeneity of autoimmune diabetes: age at presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). Diabetologia 42:608-616
24. Pozzilli P, Di Mario U 2001 Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult). Diabetes Care 24:1460-1467
25. Weets I, Siraux V, Daubresse JC, De Leeuw IH, Fery F, Keymeulen B, Krzentowski G, Letiexhe M, Mathieu C, Nobels F, Rottiers R, Scheen A, Van Gaal L, Schuit FC, Van der Auwera B, Rui M, De Pauw P, Kaufman L, Gorus FK 2002 Belgian Diabetes Registry: relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthood. J Clin Endocrinol Metab 87:2597-2605
26. Kyvik KO, Nystrom L, Gorus F, Songini M, Oestman J, Castell C, Green A, Guyrus E, Ionescu-Tirgoviste C, Mckinney PA, Michalkova D, Ostrauskas R, Raymond NT 2004 The epidemiology of type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia 47:377-384
27. Tsiavou A, Hatziagelaki E, Chaidaroglou A, Manginas A, Koniavitou K, Degiannis D, Raptis SA 2004 TNF-α, TGF-β1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus. J Clin Immunol 26:591-599
28. Novota P, Kolostova K, Pinterova D, Novak J, Treslova L, Andel M, Cerna M 2005 Interleukin-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults. Immunol Lett 96:247-251
29. Hornum L, Markholst H 2004 New autoimmune genes and the pathogenesis of type 1 diabetes. Curr Diabet Rep 4:135-142
30. Bach JF 2002 The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347:911-920
31. Serrano-Rìos M, Goday A, Martinez Larrad T 1999 Migrant populations and the incidence of type 1 diabetes mellitus: an overview of the literature with a focus on the Spanish-heritage countries in Latin America. Diabetes Metab Res Rev 15:113-132
32. Bodansky HJ, Saines A, Stephenson C, Haigh D, Cartwright R 1992 Evidence for an environmental effect in the aetiology of insulin dependent diabetes in a transmigratory population. Br Med J 304:1020-1022
33. Staines A, Hanif S, Ahmed S, Mckinney PA, Shera S, Bodansky HJ 1997 Incidence of insulin-dependent diabetes mellitus in Karachi, Pakistan. Arch Dis Child 76:121-123
34. Muntoni S, Fonte MT, Stoduto S, Marietti G, Bizzarri C, Crino A, Ciampalini P, Multari G, Suppa MA, Matteoli MC, Lucentini L, Sebastiani LM, Visalli N, Pozzilli P, Boscherini B, Muntoni S 1997 Incidence of insulin-dependent diabetes mellitus among Sardinian-heritage children born in Lazio region, Italy. Lancet 349:160-162
35. Ziegler AG, Hummel M, Schenker M, Bonifacio E 1999 Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB study. Diabetes 48:460-468
36. Lindberg B, Ivarsson S-A, Landin-Olsson M, Sundkvist G, Svanberg L, Lernmark A 1999 Islet autoantibodies in cord blood from children who developed type 1 (insulin-dependent) diabetes mellitus before 15 years of age. Diabetologia 42:181-187
37. Hamalanian A-M, Savola K, Kulmala PK, Koskela P, Akerblom HK, Knip M, The Finnish TRIGR Study Group 2001 Disease-associated autoantibodies during pregnancy and at birth in families affected by type 1 diabetes. Clin Exp Immunol 126:231-236
38. Kupila A, Keskinen P, Simell T, Erkkila, Arvilommi P, Korhonen S, Kimpimaki T, Sjoroos M, Ronkainen M, Ilonen J, Knip M, Simell O 2002 Genetic risk determines the emergence of diabetes-associated autoantibodies in young children. Diabetes 51:646-651
39. Kukko M, Kimpimaki T, Korhonen S, Kupila A, Simell S, Veijola R, Simell T, Ilonen J, Simell O, Knip M 2005 Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. J Clin Endocrinol Metab 90:2012-2717
40. Bottazzo GF, Bosi E, Cull CA, Bonifacio E, Locatelli M, Zimmet P, Mackay IR, Holman RR 2005 IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). Diabetologia 48:703-708
41. Davis TM, Wright AD, Mehta ZM, Cull CA, Stratton IM, Bottazzo GF, Bosi E, Mackay IR, Holman RR 2005 Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70). Diabetologia 48:695-702
42. Greenbaum CJ, Cuthbertson D, Krischer JP, Disease Prevention Trial of Type I Diabetes Study Group 2001 Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria. Diabetes 50:470-476
43. Eisenbarth GS 2004 Prediction of type 1 diabetes: the natural history of the prediabetic period. Adv Exp Med Biol 552:268-290
44. Pipeleers D, Ling Z 1992 Pancreatic β cells in insulin-dependent diabetes. Diabetes Metab Rev 8:209-227
45. Keskinen P, Korhonen S, Kupila A, Veijola R, Erkkila S, Savolainen H, Arvilommi P, Simell T, Ilonen J, Knip M, Simell O 2002 First-phase insulin response in young healthy children at genetic and immunological risk for type I diabetes. Diabetologia 45:1639-1648
46. Kibirige M, Metcalf B, Renuka R, Wilkin TJ 2003 Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes. Diabetes Care 26:2865-2870
47. Bingley PJ, Bonifacio E, Gale EA 1993 Can we really predict IDDM? Diabetes 42:213-220
48. Gorus FK 1997 Diabetes registries and early biological markers of insulin-dependent diabetes mellitus. Belgian Diabetes Registry. Diabetes Metab Rev 13:247-274
49. Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM, Eisenbarth GS, Rewers M, Diabetes Autoimmunity Study in Young 2004 Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). J Clin Endocrinol Metab 89:3896-3902
50. Pozzilli P, Visalli N, Buzzetti R, Cavallo MG, Marietti G, Hawa M, Leslie RD 1998 Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study. IMDIAB Study Group. Metabolism 47:1205-1210
51. The DCCT Research Group 1987 Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual β-cell function: observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT). J Clin Endocrinol Metab 65:30-36
52. Bonfanti R, Bazzigaluppi E, Calori G, Riva MC, Viscardi M, Bognetti E, Meschi F, Bosi E, Chiumello G, Bonifacio E 1998 Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with type 1 diabetes mellitus. Diabet Med 15:844-850
53. Martin S, Pawlowski B, Greulich B, Ziegler AG, Mandrup-Poulsen T, Mahon J 1992 Natural course of remission in IDDM during 1st yr after diagnosis. Diabetes Care 15:66-74
54. Palmer JP, Fleming GA, Greenbaum CJ, Herold KC, Jansa LD, Kolb H, Lachin JM, Polonsky KS, Pozzilli P, Skyler JS, Steffes MW 2004 C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve β-cell function. Diabetes 53:250-264
55. Gottsater A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G 1993 β-Cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care16:902-910
56. Borg H, Gottsater A, Landin-Olsson M, Fernlund P, Sundkvist G 2001 High levels of antigen-specific islet antibodies predict future β-cell failure in patients with onset of diabetes in adult age. J Clin Endocrinol Metab 86:3032-3038
57. Carlsson A, Sundkvist G, Groop L, Tuomi T 2000 Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab 85:76-80
58. Behme MT, Dupre J, Harris SB, Hramiak IM, Mahon JL 2003 Insulin resistance in latent autoimmune diabetes of adulthood. Ann NY Acad Sci 1005:374-377
59. Baroni M, Vialettes B, Pozzilli P 1997 The Glucose Evaluation Trial for Remission (GETREM): a European effort to evaluate insulin-dependent diabetes mellitus in the first year after diagnosis. Diabetes Metab 23:264-265
60. Palmer J 2000 Therapeutic importance of subset of type 2 diabetes? Diabetes Care 23:574-575
61. Moruyama T, Shimada A, Kanatsuka A, Kasuga A, Takei I, Yokoyama J, Kobayashi T 2003 Multicenter prevention trials of slowly progressive type 1 diabetes with small dose of insulin (the Kyoto study): preliminary report. Ann NY Acad Sci 1005:362-369
62. Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D 2003 Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care 26:138-143
63. Beales PE, Pozzilli P 2002 Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse: implications for human type 1 diabetes. Diabetes Metab Res Rev 18:114-117
64. Zhou Z, Li X, Huang G, Peng J, Yang L, Yan X, Wang J 2005 Rosiglitazone combined with insulin preserves islet β cell function in adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev 21:203-208
65. Agardh CD, Cilio CM, Lethagen A, Lynch K, Leslie RD, Palmer M, Harris RA, Robertson JA, Lernmark A 2005 Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes. J Diabetes Complications 19:238-246
66. Raz I, Elias D, Avron A, Tamir M, Metzger M, Cohen IR 2001 β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (diaPep277): a randomised, double-blind, phase two trial. Lancet 358:1749-1753
67. Brugman S, Klatter FA, Visser J, Bos NA, Elias D, Rozing J 2004 Neonatal oral administration of DiaPep277, combined with hydrolysed casein diet, protects against type 1 diabetes in BB-DP rats. An experimental study. Diabetologia 47:1331-1333